Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $35.4M | 0.04% |
357,428
+320,306
| +863% | +$32.5M |
|
477
FirstEnergy
FE
$28B
| $35.4M | 0.04% |
1,105,720
+349,849
| +46% | +$12.3M |
|
|
CELG
478
PUT
DELISTED
Celgene Corp
CELG
| $35.4M | 0.04% |
421,200
-136,800
| -25% | -$10.8M |
|
479
Regeneron Pharmaceuticals
REGN
$78.5B
| $35.3M | 0.04% |
128,376
-12,375
| -9% | -$3.56M |
|
480
PUT
Gilead Sciences
GILD
$162B
| $35.3M | 0.04% |
470,600
-730,200
| -61% | -$50.8M |
|
481
Invesco
IVZ
$13.1B
| $35.1M | 0.04% |
+974,233
| New | +$33M |
|
482
PUT
Ford
F
$58.5B
| $34.9M | 0.04% |
2,325,100
+298,400
| +15% | +$5M |
|
483
CALL
Energy Transfer Partners
ET
$70.1B
| $34.8M | 0.04% |
1,720,800
+1,426,000
| +484% | +$25.7M |
|
484
General Dynamics
GD
$104B
| $34.8M | 0.04% |
366,519
-104,406
| -22% | -$9.32M |
|
485
Tapestry
TPR
$30.8B
| $34.8M | 0.04% |
621,554
-60,927
| -9% | -$3.29M |
|
|
MRO
486
DELISTED
Marathon Oil Corporation
MRO
| $34.7M | 0.04% |
990,657
-50,700
| -5% | -$1.81M |
|
487
Agilent Technologies
A
$39.1B
| $34.6M | 0.04% |
848,713
-84,746
| -9% | -$3.22M |
|
488
CALL
Wells Fargo
WFC
$261B
| $34.6M | 0.04% |
769,000
-295,600
| -28% | -$12.8M |
|
489
Kohl's
KSS
$2.17B
| $34.4M | 0.04% |
615,027
+95,585
| +18% | +$5.24M |
|
|
EGN
490
PUT
DELISTED
Energen
EGN
| $34.2M | 0.04% |
+488,100
| New | +$36.7M |
|
491
Waste Management
WM
$90.6B
| $33.9M | 0.03% |
770,238
-17,423
| -2% | -$761K |
|
|
492
PUT
AT&T
T
$159B
| $33.8M | 0.03% |
1,279,646
-1,009,550
| -44% | -$26.6M |
|
493
Essex Property Trust
ESS
$18.3B
| $33.8M | 0.03% |
236,236
+106,372
| +82% | +$16.3M |
|
494
PG&E
PCG
$38.3B
| $33.7M | 0.03% |
842,990
+195,355
| +30% | +$8.01M |
|
495
AutoZone
AZO
$49.2B
| $33.7M | 0.03% |
70,652
-4,188
| -6% | -$1.88M |
|
|
XVZ
496
DELISTED
iPath S&P 500 Dynamic VIX ETN
XVZ
| $33.6M | 0.03% |
1,019,154
+482,289
| +90% | +$17.4M |
|
497
FMC
FMC
$1.34B
| $33.6M | 0.03% |
516,753
+417,706
| +422% | +$26.5M |
|
498
CALL
Mastercard
MA
$506B
| $33.6M | 0.03% |
402,000
+47,000
| +13% | +$3.49M |
|
499
CALL
Liberty Global Class A
LBTYA
$3.62B
| $33.5M | 0.03% |
+914,080
| New | +$30.6M |
|
500
CALL
US Bancorp
USB
$98.2B
| $33.4M | 0.03% |
834,800
-665,800
| -44% | -$25.5M |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.88B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.